Pfizer Raises 2026 Revenue Outlook to $62B–$64B and Adjusted EPS to $2.95–$3.05

Source Summary

Pfizer has raised its 2026 financial guidance, projecting revenue of $62 billion to $64 billion and adjusted earnings per share of $2.95 to $3.05. The company also targets high single-digit revenue compound annual growth rate from 2028 through 2033.

Why it matters

Pfizer's raised guidance signals management confidence in its financial trajectory and provides investors with updated expectations for near-term and medium-term revenue and profitability.

Read the Source

• Seeking Alpha ↗